Insider · CIK 0001677660

Sallin Aymeric

Reports to the SEC for 1 company · WATERTOWN, MA

sec.gov

Transactions

Companies

Filings

CIK

0001677660

Forms 4 and 5

Insider transactions

16 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-01-02	RNACCartesian Therapeutics, Inc.A Award	Director	AAward	+178K sh	—	—	178,000
2024-01-02	RNACCartesian Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+228K sh	—	—	228,000
2023-11-13	RNACCartesian Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−6,410 sh	—	—	0
2023-11-13	RNACCartesian Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2023-11-13	RNACCartesian Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2023-11-13	RNACCartesian Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2023-11-13	RNACCartesian Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−40K sh	—	—	0
2023-11-13	RNACCartesian Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−40K sh	—	—	0
2023-11-13	RNACCartesian Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−75K sh	$0.93	−$69.8K	0
2023-01-02	RNACCartesian Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+75K sh	—	—	75,000
2022-01-03	RNACCartesian Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2021-03-30	RNACCartesian Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2020-06-19	RNACCartesian Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2019-06-14	RNACCartesian Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2018-06-15	RNACCartesian Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2017-06-16	RNACCartesian Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+6,410 sh	—	—	6,410

Recent filings

Accepted (ET)
Jan 44
Sallin Aymeric0001453687-24-000024
SEC(opens sec.gov)
Nov 154
Sallin Aymeric0001453687-23-000084
SEC(opens sec.gov)
Jan 44
Sallin Aymeric0001453687-23-000017
SEC(opens sec.gov)
Jan 54
Sallin Aymeric0001453687-22-000022
SEC(opens sec.gov)
Apr 14
Sallin Aymeric0001453687-21-000047
SEC(opens sec.gov)
Jun 234
Sallin Aymeric0001453687-20-000078
SEC(opens sec.gov)
Jun 184
Sallin Aymeric0001453687-19-000073
SEC(opens sec.gov)
Jun 194
Sallin Aymeric0001638599-18-000672
SEC(opens sec.gov)
Jun 204
SELECTA BIOSCIENCES INC0001638599-17-000639
SEC(opens sec.gov)

Companies

Cartesian Therapeutics, Inc.DirectorRNAC

Address

C/O SELECTA BIOSCIENCES, INC.

WATERTOWN, MA, 02472